Xiaomin Song

机构：Chinese Academy of Sciences, Hemostasis and Thrombosis Research Society, Shanghai Institutes for Biological Sciences, Beijing Enterprises (China), 81th Hospital of PLA, Center for Excellence in Molecular Cell Science, Thrombosis Research Institute, American Thrombosis and Hemostasis Network · ORCID：0000-0002-2586-9285

发表论文 230 篇 · 总被引 10280 次 · h-index 51

代表论文

• Development of 3-arylaminothiophenic-2-carboxylic acid derivatives as new FTO inhibitors showing potent antileukemia activities (2025 · European Journal of Medicinal Chemistry · 被引 10)
• CCDC 1504873: Experimental Crystal Structure Determination (2026 · Open MIND · 被引 6)
• A highly selective PI3Kδ inhibitor BGB-10188 shows superior preclinical anti-tumor activities and decreased on-target side effects on colon (2024 · Neoplasia · 被引 5)
• Abstract 5461: BG-C477, a novel topoisomerase 1 inhibitor-based ADC, exhibits antitumor activity in carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)-expressing preclinical models (2025 · Cancer Research · 被引 4)
• Non-invasive urinary proteomic biomarkers for prognostic assessment in sepsis (2025 · Scientific Reports · 被引 3)
• Abstract P4-10-06: Preclinical characterization of BGB-43395, a potential best-in-class CDK4 selective inhibitor with potent pharmacodynamic and anti-tumor activity in HR+HER2- breast cancer models (2025 · Clinical Cancer Research · 被引 2)